Corporate responsibilities for access to medicines

Journal of Business Ethics

Volumn 85, Issue SUPPL. 1, 2009, Pages 3-23

  Leisinger, Klaus M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Determinants of health; Fair distribution of societal responsibilities; Hierarchy of corporate responsibilities; Right to health; The pharmaceutical industry

Indexed keywords

EID: 65049086302     PISSN: 01674544     EISSN: 15730697     Source Type: Journal    
DOI: 10.1007/s10551-008-9944-4     Document Type: Conference Paper

References (70)

1. Abbasi, K.: 1999, 'Healthcare Strategy', British Medical Journal 318, 933-1006
2. Anand, S., & K. HansonK. 2006. Disability-Adjusted Life Years: A Critical Review. In Anand, S., Peter, F., & Sen, A., (eds). Public Health, Ethics and Equity. Oxford: Oxford University Press
3. A. Attaran 2004 How do Patents and Economic Policies Affect Access to Essential Medicines in Developing Countries? Health Affairs 23 3 155 166
4. Baird, M. and S. Shetty: 2003, 'Getting There How to Accelerate Progress Toward the Millennium Development Goals', Finance & Development, 14-19. Article Available Online at http://www.imf.org/external/pubs/ft/fandd/2003/12/ pdf/baird.pdf
5. Bate, R., R. Tren, L. Mooney and K. Boateng: 2006, 'Tariffs, Corruption and Other Impediments to Medicinal Access in Developing Countries: Field Evidence', Working Paper 130, American Enterprise Institute, Accessed 12 September 2008. http://www.aei.org/publications/pubID.24749/pub-detail.asp
6. Bates, R.: 2006, 'Taxed to Death', Foreign Policy
7. Beynon, K. & Porter, A., 2000. Valuing Pharmaceutical Companies: A Guide to the Assessment and Evaluation of Assets, Performance and Prospects. Cambridge: Woodhead
8. A. K. Buchholtz A. C. Amason M. A. Rutherford 1999 Beyond Resources. The Mediating Effect of Top Management Discretion and Value on Corporate Philanthropy Business & Society 38 2 167 187
9. Business and Human Rights Resource Center: www.business-humanrights.org/ Home
10. Cagir, D.: 2005, 'Agency Costs or Advertising? Corporate Donations for Tsunami Relief', Claremont McKenna College Leadership Review 5, 90-109
11. nd edt. Cincinnati: South-Western Publishing Co
12. Chen, S. and M. Ravallion: 2007, 'Absolute Poverty Measures for the Developing World 1981-2004', Proceedings of the National Academy of Science of United States of America 104(43), 16757 f. www.pnas.org/cgi/reprint/ 0702930104v1.pdf
13. Commission on Macroeconomics and Health: 2003, 'Increasing Investments in Health Outcomes for the Poor', 2nd Consultation, Geneva. www.who.int/ macrohealth/events/health-for-poor/en/E-REPORT.pdf
14. Dahrendorf, R. 1959. Homo Sociologicus. Cologne: Opladen
15. Daniels, N., et al.: 2006, 'Health and Inequality, or, Why Justice is Good for Our Health', in S. Anand, F. Peter and A. Sen (eds.), Public Health, Ethics and Equity (Oxford University Press, Oxford)
16. Danish Institute for Human Rights: 'Guidelines for Compliance with the Right to Health of the Human Rights Compliance', www.humanrights.dk
17. Department for International Development, Department of Health, Department of Trade and Industry: 2005, Increasing People's Access to Essential Medicines in Developing Countries: A Framework for Good Practices in the Pharmaceutical Industry. A UK Government Policy Paper, London
18. Department of International Development, Department of Health et al.: 2004, Increasing Access to Essential Medicines in the Developing World. UK Government Policy and Plans. London
19. Donaldson, T., & Dunfee, T.E., 1999. Ties that Bind: A Social Contracts Approach to Business Ethics. Boston: Harvard Business School Press
20. Drèze, J., & Sen, A., 1989. Hunger and Public Action. Oxford: Clarendon Press
21. EU High Level Committee on Health: http://ec.europa.eu/health/ph- overview/Documents/ke02-en.pdf
22. Filmer, D., J. Hammer and L. Pritchett: 1999, Health Policy in Poor Countries: Weak Links in the Chain. World Bank Policy Research Working Paper No. 1874, Washington, DC
23. Friedman, M. 1962. Capitalism and Freedom (Fortieth Anniversary Edition). Chicago: The University of Chicago Press
24. D. C. Hambrick P. A. Mason 1984 Upper Echelons: The Organization as a Reflection of Its Top Managers Academy of Management Review 9 2 193 206
25. Hardin, G.: 1976, 'The Tragedy of the Commons', in M. D. Bayles (ed.), Ethics and Population (Schenkman Publishing Company Inc., Cambridge, Mass.)
26. Henkin, L.: 1999, 'The Universal Declaration at 50 and the Challenges of Global Markets', Brooklyn Journal of International Law XXV(1), 25
27. IFPMA: http://www.ifpma.org/Issues/GlobalHealth/fileadmin/templates/ ifpmaissues/pdfs/2008-02-27-Contrib-2-Global-Health-Final-Industry-Focus-and- Actions-EN.pdf
28. IFPMA: 2008, Principal Focus and Action of the Research-Based Pharmaceutical Industry in Contributing to Global Health (Mimeo), Geneva
29. Jones, G. R.: 2000, Personal Values and Corporate Philanthropy - A Theoretical Model for the Role Senior Executives' Personal Values Play in Decisions Regarding Corporate Philanthropy. Flinders University of South Australia. School of Commerce Research Paper Series: 0023, December 2000
30. Leisinger, K. M.: 1985, 'Health Policy for Least Developed Countries', Basel. Available through the Novartis Foundation for Sustainable Development, www.novartisfoundation.org
31. K. M. Leisinger 2007 Capitalism with a Human Face Journal of Corporate Citizenship 28 113 132
32. K. M. Leisinger 2007 Corporate Philanthropy: The "Top of the Pyramid" Business and Society Review 112 3 315 342
33. Leisinger, K. M.: Forthcoming, The Business Case for Corporate Responsibility (Novartis Foundation for Sustainable Development, Basel), www.novartisfoundation.org
34. L. D. Lerner G. E. Fryxell 1994 CEO Stakeholder Attitudes and Corporate Social Activity in the Fortune 500 Business & Society 33 1 58 81
35. Lodge, G., & Wilson, C., 2006. A Corporate Solution to Global Poverty. How Multinationals can help the Poor and Invigorate their own Legitimacy. Princeton and Oxford: Princeton University Press
36. Luhmann, N.: 1996, in J. Bednarz and D. Baecker (eds.), Social Systems (Writing Science) (Stanford University Press, Stanford)
37. Manton, K. G. and X. Gu: 2001, 'Changes in the Prevalence of Chronic Disability in the United States Black and Non-Black Population Above Age 65 from 1982 to 1999', Proceedings of the National Academy of Sciences of United States of America 98(11), 6354-6359
38. Marmot, M. 2006. Social Causes of Social Inequalities in Health. In Anand, S., Peter, F., & Sen, A., (eds) Public Health, Ethics and Equity. Oxford: Oxford University Press
39. Maturana, H., & Vaerla, F. 1979. Autopoiesis and Cognition. Boston: Reidel
40. Médecins Sans Frontières: www.msf.org/search/index.cfm? searchCriteria=access+to+medicine
41. Milken Institute: 2007, An Unhealthy America: The Economic Burden of Chronic Disease - Charting a New Course to Save Lives and Increase Productivity and Economic Growth (Santa Monica)
42. C. J. L. Murray 1994 Quantifying the Burden of Disease: The Technical Base for Disability-Adjusted Life Years. WHO Bulletin of the World Health Organization 72 429 445
43. Myrdal, G. 1968. Asian Drama. An Inquiry into the Poverty of Nations. I. Harmondswortrh: Pelican
44. Narayan, D. et al.: 2000, Voices of the Poor. Can Anyone Hear Us? (Oxford University Press, Oxford/World Bank, Washington, DC)
45. Nikièma, B., S. Haddad and L. Potvin: 2008, 'Women Bargaining to Seek Healthcare: Norms, Domestic Practices, and Implications in Rural Burkina Faso', World Development 36(4), 608-624
46. Novartis Foundation for Sustainable Development: www.novartisfoundation. org
47. Nuffield Council on Bioethics: 2007, Public Health: Ethical Issues (London)
48. OECD: 2005, Health Data 2004 (OECD, Paris)
49. Oxfam: 2007, Investing for Life. Meeting Poor People's Needs for Access to Medicines Through Responsible Business Practices. Oxfam Briefing Paper No. 109, London
50. Population Reference Bureau: 2007, 'World Population Data Sheet', www.prb.org/Publications/Datasheets/2007/2007WorldPopulationDataSheet.aspx
51. Riegler A.: 2005, 'Editorial. The Constructivist Challenge', Constructivist Foundation 1(1), 1-8
52. Sachs J.D. 2008a. Common Wealth. Economics for a Crowded Planet. New York: The Penguin Press
53. Sachs, J. D.: 2008b, 'Primary Health for All', Scientific American, January 2008
54. Sen, A. 1999. Development as Freedom. Oxford: Oxford University Press
55. Sen, A. 2006. Why Health Equity? In Anand, S., Peter, F., & Sen, A., (eds) Public Health, Ethics and Equity. Oxford: Oxford University Press
56. R. Solomon 1992 Corporate Roles, Personal Values: An Aristotelian Approach to Business Ethics Business Ethics Quarterly 2 317 340
57. S. Spinaci D. Heymann 2001 Communicable Disease and Disability of the Poor Development 44 1 66 f
58. Streeten, P. (1975). Vorwort. Myrdal, G. Das Wertproblem in der Sozialwissenschaft. 2nd edition. Bonn: Neue Gesellschaft
59. U.K. Department for International Development: 2006, Fact Sheet: Access to Medicines (London)
60. U.N. Development Program: 2005, Human Development Report 2005: International Cooperation at a Crossroads (Oxford University Press, Oxford)
61. U.N. Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health: 2007, 'Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines', Draft for Consultation. Geneva, 19 September 2007. http://www2.essex.ac.uk/ human-rights-centre/rth/docs/PH%20draft%20guidelines%2019%20sept%202007.doc
62. von Foerster, H. 2003. Understanding understanding. New York: Springer
63. von Glasersfeld, E. 1995. Radical Constructivism. A Way of Knowing and Learning. London: Falmer Press
64. Watzlawick, P. (ed.): 1984, The Invented Reality: How do We Know What We Believe We Know? (W.W. Norton, New York)
65. F. Wettstein 2005 From Causality to Capability. Towards a New Understanding of the Multinational Corporation's Enlarged Global Responsibilities Journal of Corporate Citizenship 19 105 117
66. WHO: 2000, The World Health Report 2000. Health Systems: Improving Performance (World Health Organization, Geneva)
67. WHO: 2002a, 25 Questions and Answers on Health & Human Rights. Health & Human Rights Publication Series, No. 1. World Health Organization, Geneva
68. World Health Organization: 2002b, The Lancet 360(9343), 1347-1360
69. WHO: 2007, Everybody's Business. Strengthening Health Systems to Improve Health Outcomes. WHO's Framework for Action (World Health Organization, Geneva)
70. Winslow, C.-E. A.: 1951, The Cost of Sickness and the Price of Health (World Health Organization, Geneva)